My research focuses on advancing precision approaches to the diagnosis and treatment of inflammatory bowel diseases (IBD), particularly ulcerative colitis and Crohn’s disease. I use multi-omics tools—including metagenomics, metabolomics, and single-cell transcriptomics—to investigate how immune, microbial, and metabolic pathways drive disease mechanisms and therapeutic responses. I have led translational studies on dietary interventions, am developing a noninvasive, breath-based diagnostic platform for IBD monitoring, and am currently evaluating the therapeutic potential of statins in advancing Crohn’s-related stricture treatment outcome. Broadly, my academic interests lie at the intersection of systems biology, clinical research, and therapeutic innovation, with the goal of informing individualized, mechanism-driven strategies to improve patient care.